-
公开(公告)号:US11174311B2
公开(公告)日:2021-11-16
申请号:US16470999
申请日:2017-12-13
申请人: UCB BIOPHARMA SRL , SANOFI
发明人: Alastair David Griffiths Lawson , Daniel John Lightwood , Rebecca Jayne Munro , James Philip O'Connell , John Robert Porter
IPC分类号: C07K16/24
摘要: It has been demonstrated that certain compounds bind to TNF and stabilise a conformation of trimeric TNF that binds to the TNF receptor. Antibodies which selectively bind to complexes of such compounds with TNF superfamily members are disclosed. These antibodies may be used to detect further compounds with the same activity, and as target engagement biomarker.
-
2.
公开(公告)号:US10969393B2
公开(公告)日:2021-04-06
申请号:US15736535
申请日:2015-10-22
申请人: UCB Biopharma SRL
发明人: James Philip O'Connell , John Robert Porter , Alastair Lawson , Daniel John Lightwood , Rebecca Jayne Munro
IPC分类号: C07D401/14 , C07K14/525 , C07D471/00 , C07K14/705 , C07K16/24 , C07D213/72 , C07D235/04 , C07D239/26 , C07D471/04 , A61K47/64 , A61P37/00 , A61P35/00 , G01N33/68
摘要: It has been demonstrated that certain compounds bind to TNF and stabilise a conformation of trimeric TNF that binds to the TNF receptor. Antibodies which selectively bind to complexes of such compounds with TNF superfamily members are disclosed. These antibodies may be used to detect further compounds with the same activity, and as target engagement biomarker.
-
公开(公告)号:US11674967B2
公开(公告)日:2023-06-13
申请号:US17013326
申请日:2020-09-04
申请人: UCB BIOPHARMA SRL
发明人: James Philip O'Connell , John Robert Porter , Alastair Lawson , Boris Kroeplien , Stephen Edward Rapecki , Timothy John Norman , Graham John Warrellow , Tracy Lynn Arakaki , Alex Buntin Burgin , William Ross Pitt , Mark Daniel Calmiano , David Andreas Schubert , Daniel John Lightwood , Rebecca Jayne Munro
IPC分类号: G01N33/68 , C07D401/14 , C07K14/525 , C07D471/00 , C07K14/705 , C07K16/24 , C07D213/72 , C07D235/04 , C07D239/26 , C07D471/04 , A61K47/64 , A61P37/00 , A61P35/00
CPC分类号: G01N33/6845 , A61K47/6425 , A61P35/00 , A61P37/00 , C07D213/72 , C07D235/04 , C07D239/26 , C07D401/14 , C07D471/00 , C07D471/04 , C07K14/525 , C07K14/70575 , C07K16/241 , G01N33/6854 , G01N33/6863 , C07K2317/55 , C07K2317/92 , G01N2333/525 , G01N2500/02
摘要: A new, stable trimeric TNFα structure is disclosed with distorted symmetry which can bind to the TNFR1 receptor to attenuate signalling therefrom, which can be used in the treatment and/or prevention of diseases associated with the soluble TNFα/TNFR1 interaction. Membrane-bound TNFα is not affected in its ability to signal through TNFR2, and thus the new structure of TNFα may be used in therapies which do not significantly raise the risk of infection or malignancy.
-
4.
公开(公告)号:US10935553B2
公开(公告)日:2021-03-02
申请号:US15736535
申请日:2015-10-22
申请人: UCB Biopharma SRL
发明人: James Philip O'Connell , John Robert Porter , Alastair Lawson , Daniel John Lightwood , Rebecca Jayne Munro
IPC分类号: C07D401/14 , C07K14/525 , C07D471/00 , C07K14/705 , C07K16/24 , C07D213/72 , C07D235/04 , C07D239/26 , C07D471/04 , A61K47/64 , A61P37/00 , A61P35/00 , G01N33/68
摘要: It has been demonstrated that certain compounds bind to TNF and stabilise a conformation of trimeric TNF that binds to the TNF receptor. Antibodies which selectively bind to complexes of such compounds with TNF superfamily members are disclosed. These antibodies may be used to detect further compounds with the same activity, and as target engagement biomarker.
-
5.
公开(公告)号:US11448655B2
公开(公告)日:2022-09-20
申请号:US16883859
申请日:2020-05-26
申请人: UCB BIOPHARMA SRL
发明人: James Philip O'Connell , John Robert Porter , Alastair Lawson , Boris Kroeplien , Stephen Edward Rapecki , Timothy John Norman , Graham John Warrellow
IPC分类号: G01N33/68 , C07K14/525 , C07K16/24 , A61K47/64 , A61P37/00 , A61P35/00 , C07D401/14 , C07D471/00 , C07K14/705 , C07D213/72 , C07D235/04 , C07D239/26 , C07D471/04
摘要: It has been demonstrated that certain compounds bind to TNF and stabilise a conformation of trimeric TNF that binds to the TNF receptor. Accordingly, these compounds can be used as modulators of TNF. A new assay for identifying compounds with this mechanism of action is also disclosed.
-
公开(公告)号:US10883996B2
公开(公告)日:2021-01-05
申请号:US15736336
申请日:2015-10-22
申请人: UCB BIOPHARMA SRL
发明人: James Philip O'Connell , John Robert Porter , Alastair Lawson , Boris Kroeplien , Stephen Edward Rapecki , Timothy John Norman , David James McMillan , Graham John Warrellow , Daniel Christopher Brookings , Rikki Peter Alexander
IPC分类号: G01N33/68 , C07K14/525 , C07K14/705 , C07K16/24 , C07D401/14 , C07D471/00 , C07D213/72 , C07D235/04 , C07D239/26 , C07D471/04 , A61K47/64 , A61P37/00 , A61P35/00
摘要: The invention is in the field of TNF signalling. Compounds have been identified which are capable of modulating signalling of TNF trimers through receptors. Methods of identifying such compounds are therefore provided. The compounds themselves have utility in therapy.
-
公开(公告)号:US10705094B2
公开(公告)日:2020-07-07
申请号:US15736520
申请日:2015-10-22
申请人: UCB Biopharma SRL
发明人: James Philip O'Connell , John Robert Porter , Alastair Lawson , Boris Kroeplien , Stephen Edward Rapecki , Timothy John Norman , Graham John Warrellow
IPC分类号: G01N33/68 , C07K14/525 , C07K14/705 , C07K16/24 , A61K47/64 , A61P37/00 , C07D401/14 , C07D471/00 , C07D213/72 , C07D235/04 , C07D239/26 , C07D471/04 , A61P35/00
摘要: It has been demonstrated that certain compounds bind to TNF and stabilise a conformation of trimeric TNF that binds to the TNF receptor. Accordingly, these compounds can be used as modulators of TNF. A new assay for identifying compounds with this mechanism of action is also disclosed.
-
公开(公告)号:US12055549B2
公开(公告)日:2024-08-06
申请号:US17325036
申请日:2021-05-19
申请人: UCB Biopharma SRL , SANOFI
发明人: James Philip O'Connell , John Robert Porter , Alastair Lawson , Tracy Lynn Arakaki , Daniel John Lightwood , Rebecca Jayne Munro
IPC分类号: G01N33/68 , A61K47/64 , A61P35/00 , A61P37/00 , C07D213/72 , C07D235/04 , C07D239/26 , C07D401/14 , C07D471/00 , C07D471/04 , C07K14/525 , C07K14/705 , C07K16/24
CPC分类号: G01N33/6845 , A61K47/6425 , A61P35/00 , A61P37/00 , C07D213/72 , C07D235/04 , C07D239/26 , C07D401/14 , C07D471/00 , C07D471/04 , C07K14/525 , C07K14/70575 , C07K16/241 , G01N33/6854 , G01N33/6863 , C07K2317/55 , C07K2317/92 , G01N2333/525 , G01N2500/02
摘要: It has been demonstrated that certain compounds bind to TNF and stabilise a conformation of trimeric TNF that binds to the TNF receptor. Antibodies which selectively bind to complexes of such compounds with TNF superfamily members are disclosed. These antibodies may be used to detect further compounds with the same activity, and as target engagement biomarker.
-
公开(公告)号:US11022614B2
公开(公告)日:2021-06-01
申请号:US15736558
申请日:2015-10-22
申请人: UCB BIOPHARMA SRL , SANOFI
发明人: James Philip O'Connell , John Robert Porter , Alastair Lawson , Tracy Lynn Arakaki , Daniel John Lightwood , Rebecca Jayne Munro
IPC分类号: C07K14/525 , C07K16/24 , G01N33/68 , C07D401/14 , C07D471/00 , C07K14/705 , C07D213/72 , C07D235/04 , C07D239/26 , C07D471/04 , A61K47/64 , A61P37/00 , A61P35/00
摘要: It has been demonstrated that certain compounds bind to TNF and stabilise a conformation of trimeric TNF that binds to the TNF receptor. Antibodies which selectively bind to complexes of such compounds with TNF superfamily members are disclosed. These antibodies may be used to detect further compounds with the same activity, and as target engagement biomarker.
-
-
-
-
-
-
-
-